• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION QUANTUM MAVERICK; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION QUANTUM MAVERICK; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7015
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/30/2021
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that shaft break occurred.The 98% stenosed target lesion was located in the 60% calcified left anterior descending (lad) artery.A 3.0mm x 15mm quantum maverick balloon was advanced for dilatation; however, it was noted that the delivery shaft of the balloon was fractured.The procedure was completed with another of same device.No patient complications were reported and the patient status was stable.
 
Additional Manufacturer Narrative
Age at time of event: 18 years or older.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: returned product consisted of a quantum maverick balloon catheter.The device was visually and microscopically examined.There were numerous kinks to the hypotube of the device.There was a separation of the hypotube at 54.1cm from the strain relief.The separated ends of the hypotube were ovaled in shape indicating the device was kinked prior to separation.There was contrast in the inflation lumen and the balloon was tightly folded.There was blood in the manifold, inflation lumen, and balloon folds.The tip of the device was damaged.Photo media was received, however, photo analysis reviewed was found to be not applicable as it was a photo depicting product packaging.
 
Event or Problem Description
It was reported that shaft break occurred.The 98% stenosed target lesion was located in the 60% calcified left anterior descending (lad) artery.A 3.0mm x 15mm quantum maverick balloon was advanced for dilatation; however, it was noted that the delivery shaft of the balloon was fractured.The procedure was completed with another of same device.No patient complications were reported and the patient status was stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QUANTUM MAVERICK
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
pmt 741 persiaran cassia selat
bandarcassia, pulau pinan 14110
MY   14110
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key13256394
Report Number2134265-2021-16713
Device Sequence Number5022863
Product Code LOX
UDI-Device Identifier08714729392781
UDI-Public08714729392781
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
P860019
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/12/2024
Device Model Number7015
Device Catalogue Number7015
Device Lot Number0027128502
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/18/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 12/24/2021
Supplement Date Received by Manufacturer02/01/2022
Initial Report FDA Received Date01/13/2022
Supplement Report FDA Received Date02/23/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/13/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-